Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Martine Piccart-Gebhart Nadia Harbeck Seock-Ah Im Chiun-Sheng Huang Marek Wojtukiewicz Jacek Jassem |
| Publication date | March 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |